Search research articles
Contact Us
Filters
Showing results (161-170 of 201) with videos related to
Page
of 21
Sort By:
American Journal of Medical Genetics. Part A
|
February 13, 2013
Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria
Scott R Plotkin, Jaishri O Blakeley, D Gareth Evans, et al.
Journal of Neuro-Oncology
|
May 28, 2025
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104
Vihang Nakhate, Ina Ly, Alona Muzikansky, et al.
Nature Communications
|
February 11, 2026
NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss
Simeng Lu, Zhenzhen Yin, Limeng Wu, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
Co-Targeting IL-6 and EGFR signaling for the treatment of schwannomatosis and associated pain
Zhenzhen Yin, Limeng Wu, Yanling Zhang, et al.
Neuro-Oncology
|
July 9, 2018
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma
Steven P Angus, Janet L Oblinger, Timothy J Stuhlmiller, et al.
Genome Medicine
|
April 11, 2025
A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations
L Nicolas Gonzalez Castro, Avishai Gavish, Lillian Bussema, et al.
The British Journal of Dermatology
|
October 25, 2023
A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials
Laura Fertitta, Christina Bergqvist, Kavita Y Sarin, et al.
Neurology
|
November 20, 2013
Recommendations for imaging tumor response in neurofibromatosis clinical trials
Eva Dombi, Simone L Ardern-Holmes, Dusica Babovic-Vuksanovic, et al.
NPJ Precision Oncology
|
December 5, 2017
Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival
Ovidiu C Andronesi, Morteza Esmaeili, Ronald J H Borra, et al.
Neuro-Oncology
|
July 6, 2013
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
Christine Lu-Emerson, Matija Snuderl, Nathaniel D Kirkpatrick, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 201) with videos related to
Sort By:
Page
of 21
American Journal of Medical Genetics. Part A
|
February 13, 2013
Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria
Scott R Plotkin, Jaishri O Blakeley, D Gareth Evans, et al.
Journal of Neuro-Oncology
|
May 28, 2025
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104
Vihang Nakhate, Ina Ly, Alona Muzikansky, et al.
Nature Communications
|
February 11, 2026
NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss
Simeng Lu, Zhenzhen Yin, Limeng Wu, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
Co-Targeting IL-6 and EGFR signaling for the treatment of schwannomatosis and associated pain
Zhenzhen Yin, Limeng Wu, Yanling Zhang, et al.
Neuro-Oncology
|
July 9, 2018
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma
Steven P Angus, Janet L Oblinger, Timothy J Stuhlmiller, et al.
Genome Medicine
|
April 11, 2025
A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations
L Nicolas Gonzalez Castro, Avishai Gavish, Lillian Bussema, et al.
The British Journal of Dermatology
|
October 25, 2023
A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials
Laura Fertitta, Christina Bergqvist, Kavita Y Sarin, et al.
Neurology
|
November 20, 2013
Recommendations for imaging tumor response in neurofibromatosis clinical trials
Eva Dombi, Simone L Ardern-Holmes, Dusica Babovic-Vuksanovic, et al.
NPJ Precision Oncology
|
December 5, 2017
Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival
Ovidiu C Andronesi, Morteza Esmaeili, Ronald J H Borra, et al.
Neuro-Oncology
|
July 6, 2013
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
Christine Lu-Emerson, Matija Snuderl, Nathaniel D Kirkpatrick, et al.
Page
of 21